Two Sigma Advisers’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-7,300
| Closed | -$305K | – | 2682 |
|
|
2023
Q4 | $305K | Sell |
7,300
-5,713
| -44% | -$239K | ﹤0.01% | 2094 |
|
|
2023
Q3 | $491K | Buy |
+13,013
| New | +$491K | ﹤0.01% | 1799 |
|
|
2020
Q1 | – | Sell |
-5,100
| Closed | -$448K | – | 2595 |
|
|
2019
Q4 | $448K | Buy |
5,100
+1,100
| +28% | +$96.6K | ﹤0.01% | 1916 |
|
|
2019
Q3 | $302K | Sell |
4,000
-100
| -2% | -$7.55K | ﹤0.01% | 1920 |
|
|
2019
Q2 | $350K | Buy |
4,100
+1,200
| +41% | +$102K | ﹤0.01% | 1950 |
|
|
2019
Q1 | $313K | Buy |
2,900
+200
| +7% | +$21.6K | ﹤0.01% | 1974 |
|
|
2018
Q4 | $229K | Buy |
2,700
+300
| +13% | +$25.4K | ﹤0.01% | 2088 |
|
|
2018
Q3 | $236K | Buy |
+2,400
| New | +$236K | ﹤0.01% | 2035 |
|
|
2016
Q1 | – | Sell |
-2,900
| Closed | -$448K | – | 2159 |
|
|
2015
Q4 | $448K | Sell |
2,900
-4,500
| -61% | -$695K | ﹤0.01% | 1371 |
|
|
2015
Q3 | $1.06M | Buy |
+7,400
| New | +$1.06M | 0.01% | 990 |
|
|
2014
Q4 | – | Sell |
-1,800
| Closed | -$277K | – | 2305 |
|
|
2014
Q3 | $277K | Buy |
+1,800
| New | +$277K | ﹤0.01% | 1470 |
|